Menkes Disease
&nbsp;
Menkes disease is a lethal infantile neurodegenerative disorder with X-linked inheritance. It is an inherited X-linked recessive disorder caused by mutations in the ATP7A gene responsible for copper transport throughout the body. The mutation could lead to premature birth and may have non-specific symptoms such as hypothermia, hypoglycemia, and prolonged jaundice. These non-specific clinical and biochemical findings could result in the misdiagnosis of neonatal Menkes disease.
&nbsp;
Menkes Disease Epidemiology Segmentation in the 7MM
&nbsp;
●&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diagnosed Prevalent Cases of Menkes Disease
&nbsp;
&nbsp;
<a style="background-color: transparent; color: #1155cc;" href="https://www.delveinsight.com/report-store/menkes-disease-epidemiology-forecast" target="_blank" rel="noopener noreferrer">Menkes Disease Epidemiological Insights</a> Observed in the 7MM
(2021)
&nbsp;
<ul>
<li>The total diagnosed prevalent cases of Menkes Disease in G11 geography was found to be approximately 260 cases. China accounted for the highest prevalence, accounting for more than 80 patients.&nbsp;</li>
<li>The prevalence is second highest in the US, which was approximately 80 cases.&nbsp;</li>
<li>In the EU, the number of prevalent cases was found to be 57 cases.&nbsp;</li>
<li>In Japan, the total number of cases of Menkes Disease was 19, whereas it dropped as low in South Korea, accounting for 8 cases.&nbsp;</li>
</ul>
&nbsp;
<a style="background-color: transparent; color: #1155cc;" href="https://www.delveinsight.com/report-store/menkes-disease-market" target="_blank" rel="noopener noreferrer">Menkes Disease Market Insight</a>
&nbsp;
The market size of Menkes Disease in G11 was found to be approximately USD 0.2 million in 2021.
&nbsp;
Menkes Disease Market Strengths
&nbsp;
The slowly increasing prevalent population in the G11 is likely to cause an upsurge in treatment needs. Consequently, with the successful launch of emerging therapy, the market will witness a boost in the upcoming year.&nbsp;
&nbsp;
Menkes Disease Market Opportunities
&nbsp;
Medications with better safety and effectiveness, which provide optimum care, are the current unmet need of the Menkes disease market.&nbsp;
&nbsp;
Menkes Disease Emerging Drugs
&nbsp;
The emerging drugs in the Menkes Disease market are
&nbsp;
<ul>
<li>CUTX-101, and others</li>
</ul>
&nbsp;
Menkes DiseaseKey Players&nbsp;
&nbsp;
The key players working in the Menkes Disease market are
&nbsp;
<ul>
<li>Cyprium Therapeutics&nbsp;</li>
<li>&nbsp;</li>
<li>Sentynl Therapeutics, and others</li>
</ul>
&nbsp;

Menkes Disease

Menkes Disease Market

Menkes Disease Symptoms, Treatment, epidemiology, companies, drugs, infographic is a short guide to understand the problem and market landscape